MARSHALL & POPP, LLC for GENENTECH, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Immigration IMM
Issues related to employee VISAs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Copyright/Patent/Trademark CPT
Patents and protection of intellectual property issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Pharmacy PHA
Issues related to prescription drug value. Issues related to supply chain and Buy America requirements S.2543: Prescription Drug Pricing Reduction Act of 2019. H.R.3: Lower Drug Costs Now Act of 2019. H.R.19/S.3129: Lower Costs, More Cures Act of 2019. Biosimilars. Importation of prescription drugs. 340B issues. FDA regulatory issues, including the International Pricing Index. Issues related to the COVID-19 pandemic. H.R.6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.